CORNING. N.Y. -- Corning Incorporated (NYSE: GLW) today announced that its vice chairman and corporate development officer, Lawrence D. McRae, who has been with the company for nearly four decades, will retire at the end of the year. McRae will continue in his current role and remain on Corning’s Senior Leadership Team until his retirement. “Larry has [...]

The manufacturing facility in Pune will double Cytiva’s manufacturing capacity in India and the Experience Center will provide critical training programs to accelerate the development of novel therapeutics. According to Cytiva’s 2023 Global Biopharma Resilience Index, the manufacturing of biologics in India is likely to increase over the next three years. Cytiva’s manufacturing facility in [...]

The Schauenburg Analytics Group (Markes International & SepSolve Analytical) is pleased to announce the appointment of Nigel Fry as its Chief Executive Officer (CEO). As of September 2023, Fry became responsible for all aspects of the business operations of Schauenburg Analytics Ltd and its subsidiaries, Markes International Ltd and SepSolve Analytical Ltd. Fry joins the [...]

Increased capability to produce medicines for challenging diseases including cancer WALTHAM, Mass. -- Thermo Fisher Scientific, the world leader in serving science, today expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders. Thermo Fisher made a significant investment since 2021 [...]

SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an antibody discovery, option and license agreement with Bayer. Under the terms of the agreement, Twist Biopharma Solutions, a division of Twist Bioscience, will leverage its Library of Libraries to [...]

 Congenica platform to continue providing tertiary analysis for Whole Genome Sequencing  Cambridge, United Kingdom – Congenica, a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale, today announces a two-year extension to their contract for the Hong Kong Genome Project (HKGP), the first large-scale genome sequencing initiative in [...]

Getinge has today completed the previously announced acquisition of 100% of the shares in High Purity New England, Inc. On May 31, 2023, Getinge announced an agreement to acquire High Purity New England, Inc., a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. All conditions for the transaction and [...]

MIRO MGA systems enable fast, simultaneous trace gas analysis for Greenhouse Gases (GHGs) and pollutants for atmospheric and climate research, and industrial gas monitoring ZURICH -- Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIRO Analytical AG, an innovative provider of fast, compact Quantum Cascade Laser (QCL)-based multi-gas analyzers for simultaneous, highest-precision monitoring of up [...]

External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization  Cambridge, UK – EVONETIX LTD (‘Evonetix’), the Company developing semiconductor scale technology to improve access to gene synthesis, today announced its first placement of a DNA synthesis development platform for evaluation at Imperial College [...]

REDWOOD CITY, CA – Synthego, a leading provider of genome engineering solutions, has announced the launch of its IND-enabling (INDe) gRNAs, a transformative product offering that revolutionizes the CRISPR-based cell and gene therapy preclinical pipeline. This innovative offering empowers researchers with high-quality gRNAs designed specifically for GLP-regulated preclinical and IND-enabling studies, incorporating comprehensive IND-compliant materials and documentation [...]